首页 | 本学科首页   官方微博 | 高级检索  
   检索      


lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A
Authors:Zhaoxiong Hu  Linhong Li  Peng Cheng  Qin Liu  Xuan Zheng  Feng Peng  Qinghong Zhang
Institution:1. Department of Nephrology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China;2. Department of Geriatric Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China;3. Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China;4. Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
Abstract:Kidney renal clear cell carcinoma (KIRC) is the most general subtype of renal cell carcinoma, which composes about 1/20 of adult malignancies. The anomaly of long noncoding RNAs (lncRNAs) expression is proved to mediate cancer progression of various types. The function and mediation mechanism of MSC-AS1 has rarely been detected in KIRC before. This study started with the mediation of MSC-AS1 on cell function. In this study, MSC-AS1 was dramatically upregulated in KIRC and correlated with dismal prognosis of KIRC patients. Knockdown of MSC-AS1 would suppress the proliferative and migratory properties of KIRC cells. MSC-AS1 was found to directly downregulate miR-3924 expression while miR-3924 directly downregulated WNT5A expression. Meanwhile, MSC-AS1 could promote the expression of WNT5A, indicating the existence of MSC-AS1/miR-3924/WNT5A. Further assays indicated that MSC-AS1 could enhance Wnt/β-catenin pathway. By means of rescue assays, the mediation of MSC-AS1/miR-3924/WNT5A/β-catenin axis on KIRC cell proliferation, migration and migration was verified. This study revealed that MSC-AS1 regulates KIRC cell proliferation and migration via miR-3924/WNT5A/β-catenin axis. MSC-AS1 might contribute to new strategies for KIRC treatment.
Keywords:KIRC  MCF-AS1  miR-3924  WNT5A
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号